Skip to main content
. 2020 Sep 24;12(10):2739. doi: 10.3390/cancers12102739

Figure 2.

Figure 2

Burden of non-benign POT1 mutations across cancer types. The prevalence of POT mutations defined as neither “presumed benign” nor “benign” was investigated in 62,368 tumors. The figure shows the POT1 mutation burden in some tumor categories that included more than 50 cases (data from [65]). The number in brackets indicate the total number of cases for each cancer type.